EUDA Health Holdings Stock Math Operators Price Series Subtraction

EUDA Stock   0.50  -0.0001  -0.02%   
The math operators module provides an execution environment for Price Series Subtraction operator and related indicators on EUDA Health and Forian Inc. This view tracks relative price relationships between EUDA Health and Forian Inc to support structured performance interpretation without implying advice.

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. EUDA Health Holdings Price Series Subtraction is a subtraction of EUDA Health price series from its benchmark/peer..

EUDA Health Technical Analysis Modules

Most technical analysis of EUDA Health help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for EUDA from various momentum indicators to cycle indicators. When you analyze EUDA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

EUDA Health is publicly traded on the NASDAQ Exchange in United States. A high-level view of EUDA Health emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Current metrics include profit margin of 5.17%. EUDA Health has a market cap of 18.95 M.

Methodology

Unless otherwise specified, financial data for EUDA Health Holdings is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. EUDA (USA Stocks:EUDA) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

EUDA Health Holdings may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board

Become your own money manager

Tracking EUDA Health inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run USA ETFs Now

   

USA ETFs

Find actively traded Exchange Traded Funds (ETF) in USA
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 20 shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Social Domain Idea
Social Domain
Invested few shares
Momentum Idea
Momentum
Invested few shares
ESG Investing Idea
ESG Investing
Invested few shares
Corona Opportunity Idea
Corona Opportunity
Invested few shares
Software Idea
Software
Invested few shares
Advertising Idea
Advertising
Invested few shares
Cash Cows Idea
Cash Cows
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 20 shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares

More Resources for EUDA Stock Analysis

A structured review of EUDA Health Holdings often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Below are reports that help frame EUDA Health Holdings Stock in context:
EUDA Health has a market cap of 18.95 M, operating margin of -37.03%. Use Investing Opportunities to explore allocation context. This includes a position in EUDA Health Holdings across the allocation. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.
Analysis related to EUDA Health should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
 Earnings Share
0.02
 Revenue Per Share
0.14
 Quarterly Revenue Growth
0.602
 Return On Assets
-0.64
The market value of EUDA Health Holdings is measured differently than book value, which reflects EUDA accounting equity. EUDA Health's market capitalization is 18.95 M. Enterprise value stands at 21.09 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Note that EUDA Health's intrinsic value and market price are different measures derived from different inputs. For EUDA Health, key inputs include a profit margin of 5.17%, and revenue of 4.01 M. Trading price represents the transaction level agreed by market participants.